To sign up for our newsletter or print publications, please enter your contact information below.
Dr Morganna Freeman outlines some of the criteria used in deciding which patients will most benefit from immunotherapy.
Sunil Verma, MD, MSEd, FRCPC discusses treatment options for this type of cancer.
Two-pronged attack on chemotherapy-resistant leukemia cells
An Early Look at Research From the 2016 ASCO Annual Meeting
Drug against breast cancer is also highly potent against a frequent form of leukaemia
Improving natural killer cancer therapy: Study